Ascent Pharmaceuticals Inc

General

Total Cases26
Active Cases7
Patents1
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
L4
E
PTAB
L2
B
CAFC
L2
B

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
11/19/24
CLERK'S QUALITY CONTROL MESSAGE - Case Closed in Error, Please Disregard (ld, ) (Entered: 11/19/2024)
11/19/24
STIPULATION AND ORDER OF DISMISSAL Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii) as to INVAGEN PHARMACEUTICALS, INC.. Signed by Judge Michael E. Farbiarz on 11/18/2024. (ld, ) (Entered: 11/19/2024)
11/19/24
STIPULATION AND ORDER OF DISMISSAL Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii) as to ASCENT PHARMACEUTICALS, INC.. Signed by Judge Michael E. Farbiarz on 11/18/2024. (ld). (Main Document 334 replaced on 11/19/2024) (ld). (Entered: 11/19/2024)
11/15/24
Letter from Plaintiff to the Hon. Michael E. Farbiarz, U.S.D.J.. (LIZZA, CHARLES) (Entered: 11/15/2024)
11/05/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,6539,218 B2; 10,828,310 B2. (Attachments: # [1] Order)(nms) (Entered: 11/05/2024)
11/05/24
SO ORDERED Granting Stipulation of Dismissal (D.I. 326 in 21-md-3017-RGA-LDH; D.I. 18 in 24-cv-588-RGA) (*Hetero Labs Limited and Ascent Pharmaceuticals Inc. terminated). Signed by Judge Richard G. Andrews on 11/5/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00588-RGA(nms) (Entered: 11/05/2024)
11/05/24
STIPULATION of Dismissal with prejudice as to Defendants Ascent Pharmaceuticals Inc. and Hetero Labs Limited (C.A. 24-588), by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 11/5/2024 (nms). (Entered: 11/05/2024)
11/05/24
CASE CLOSED per entry of D.I. [19] . (nms) (Entered: 11/05/2024)
11/05/24
***Civil Case Administratively Terminated. (jd, ) (Entered: 11/05/2024)
11/05/24
***Civil Case Administratively Terminated. (jd, ) (Entered: 11/05/2024)